Cardiac regeneration - Past advancements, current challenges, and future directions.

[1]  Lauren E. Neidig,et al.  Gene editing to prevent ventricular arrhythmias associated with cardiomyocyte cell therapy. , 2023, Cell stem cell.

[2]  Paul E. Miller,et al.  Generation of left ventricle-like cardiomyocytes with improved structural, functional, and metabolic maturity from human pluripotent stem cells , 2023, Cell reports methods.

[3]  A. Windebank,et al.  The evolving regulatory landscape in regenerative medicine. , 2022, Molecular aspects of medicine.

[4]  Douglas J. Chapski,et al.  Transcriptional, Electrophysiological, and Metabolic Characterizations of hESC-Derived First and Second Heart Fields Demonstrate a Potential Role of TBX5 in Cardiomyocyte Maturation , 2021, Frontiers in Cell and Developmental Biology.

[5]  C. Dai,et al.  PiRNA pathway in the cardiovascular system: a novel regulator of cardiac differentiation, repair and regeneration , 2021, Journal of Molecular Medicine.

[6]  T. Dvir,et al.  Bioengineering approaches to treat the failing heart: from cell biology to 3D printing , 2021, Nature Reviews Cardiology.

[7]  P. Alves,et al.  Next generation of heart regenerative therapies: progress and promise of cardiac tissue engineering , 2021, NPJ Regenerative medicine.

[8]  D. Sahoo,et al.  Isolation and characterization of hESC-derived heart field-specific cardiomyocytes unravels new insights into their transcriptional and electrophysiological profiles. , 2021, Cardiovascular research.

[9]  G. Fonarow,et al.  2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee. , 2021, Journal of the American College of Cardiology.

[10]  George Z. Tan,et al.  Electrospinning of biomimetic fibrous scaffolds for tissue engineering: a review , 2020, International Journal of Polymeric Materials and Polymeric Biomaterials.

[11]  J. Morgan,et al.  Survival on the Heart Transplant Waiting List. , 2020, JAMA cardiology.

[12]  Mohammad R. Ostovaneh,et al.  Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): a randomized, placebo-controlled, double-blinded trial. , 2020, European heart journal.

[13]  T. Thum,et al.  Non-coding RNAs: emerging players in cardiomyocyte proliferation and cardiac regeneration , 2020, Basic Research in Cardiology.

[14]  Sung Yun Hann,et al.  4D physiologically adaptable cardiac patch: A 4-month in vivo study for the treatment of myocardial infarction , 2020, Science Advances.

[15]  Kelly P. Yamada,et al.  Consideration of clinical translation of cardiac AAV gene therapy. , 2020, Cell & gene therapy insights.

[16]  M. Giacca,et al.  Non-coding RNA therapeutics for cardiac regeneration. , 2020, Cardiovascular research.

[17]  T. Dvir,et al.  Electrospun Fibrous PVDF‐TrFe Scaffolds for Cardiac Tissue Engineering, Differentiation, and Maturation , 2020, Advanced Materials Technologies.

[18]  Zhenwei Pan,et al.  Targeting LncDACH1 promotes cardiac repair and regeneration after myocardium infarction , 2020, Cell Death & Differentiation.

[19]  Amit N. Patel,et al.  First-in-Man Study of a Cardiac Extracellular Matrix Hydrogel in Early and Late Myocardial Infarction Patients , 2019, JACC. Basic to translational science.

[20]  Sebastien G M Uzel,et al.  Biomanufacturing of organ-specific tissues with high cellular density and embedded vascular channels , 2019, Science Advances.

[21]  Mengying Feng,et al.  miR-199a-3p promotes cardiomyocyte proliferation by inhibiting Cd151 expression. , 2019, Biochemical and biophysical research communications.

[22]  Leming Shi,et al.  MicroRNA-302d promotes the proliferation of human pluripotent stem cell-derived cardiomyocytes by inhibiting LATS2  in the Hippo pathway. , 2019, Clinical science.

[23]  K. Yan,et al.  Long Noncoding RNA CPR (Cardiomyocyte Proliferation Regulator) Regulates Cardiomyocyte Proliferation and Cardiac Repair. , 2019, Circulation.

[24]  Joe Z. Zhang,et al.  A Human iPSC Double-Reporter System Enables Purification of Cardiac Lineage Subpopulations with Distinct Function and Drug Response Profiles. , 2019, Cell stem cell.

[25]  M. Marsili,et al.  Common Regulatory Pathways Mediate Activity of MicroRNAs Inducing Cardiomyocyte Proliferation , 2019, Cell reports.

[26]  F. Gao,et al.  Therapeutic role of miR-19a/19b in cardiac regeneration and protection from myocardial infarction , 2019, Nature Communications.

[27]  T. Dvir,et al.  3D Printing of Personalized Thick and Perfusable Cardiac Patches and Hearts , 2019, Advanced science.

[28]  Fabio Bernini,et al.  MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs , 2019, Nature.

[29]  Y. Liao,et al.  Loss of Super-Enhancer-Regulated circRNA Nfix Induces Cardiac Regeneration After Myocardial Infarction in Adult Mice , 2019, Circulation.

[30]  T. Dvir,et al.  Gold Nanoparticle-Integrated Scaffolds for Tissue Engineering and Regenerative Medicine. , 2019, Nano letters.

[31]  Mark M. Davis,et al.  Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients , 2019, Nature Biotechnology.

[32]  Zhang Yue,et al.  A long noncoding RNA NR_045363 controls cardiomyocyte proliferation and cardiac repair. , 2019, Journal of molecular and cellular cardiology.

[33]  T. Watabe,et al.  Transplantation of Human-induced Pluripotent Stem Cell-derived Cardiomyocytes Is Superior to Somatic Stem Cell Therapy for Restoring Cardiac Function and Oxygen Consumption in a Porcine Model of Myocardial Infarction , 2019, Transplantation.

[34]  V. Fast,et al.  Human Leukocyte Antigen Class I and II Knockout Human Induced Pluripotent Stem Cell–Derived Cells: Universal Donor for Cell Therapy , 2018, Journal of the American Heart Association.

[35]  Y. Liao,et al.  Long Non-coding RNA ECRAR Triggers Post-natal Myocardial Regeneration by Activating ERK1/2 Signaling , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

[36]  Jianyi Zhang,et al.  Big bottlenecks in cardiovascular tissue engineering , 2018, Communications Biology.

[37]  Y. Liao,et al.  Sirt1 Antisense Long Noncoding RNA Promotes Cardiomyocyte Proliferation by Enhancing the Stability of Sirt1 , 2018, Journal of the American Heart Association.

[38]  Y. Liao,et al.  Loss of long non-coding RNA CRRL promotes cardiomyocyte regeneration and improves cardiac repair by functioning as a competing endogenous RNA. , 2018, Journal of molecular and cellular cardiology.

[39]  Benjamin M. Wu,et al.  Harnessing the versatility of PLGA nanoparticles for targeted Cre-mediated recombination. , 2018, Nanomedicine : nanotechnology, biology, and medicine.

[40]  W. Zimmermann,et al.  Myocardial tissue engineering strategies for heart repair: current state of the art. , 2018, Interactive cardiovascular and thoracic surgery.

[41]  Zhenwei Pan,et al.  The Long Noncoding RNA CAREL Controls Cardiac Regeneration. , 2018, Journal of the American College of Cardiology.

[42]  Lil Pabon,et al.  Human ESC-Derived Cardiomyocytes Restore Function in Infarcted Hearts of Non-Human Primates , 2018, Nature Biotechnology.

[43]  Y. Liao,et al.  Loss of AZIN2 splice variant facilitates endogenous cardiac regeneration , 2018, Cardiovascular research.

[44]  Alain Bel,et al.  Transplantation of Human Embryonic Stem Cell-Derived Cardiovascular Progenitors for Severe Ischemic Left Ventricular Dysfunction. , 2018, Journal of the American College of Cardiology.

[45]  V. Fast,et al.  Large Cardiac Muscle Patches Engineered From Human Induced-Pluripotent Stem Cell–Derived Cardiac Cells Improve Recovery From Myocardial Infarction in Swine , 2017, Circulation.

[46]  Doris A Taylor,et al.  TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function Final 2-Year Analysis , 2017, Circulation research.

[47]  E. Marbán,et al.  Cardiac and systemic rejuvenation after cardiosphere-derived cell therapy in senescent rats , 2017, European heart journal.

[48]  Utkan Demirci,et al.  Bioacoustic-enabled patterning of human iPSC-derived cardiomyocytes into 3D cardiac tissue. , 2017, Biomaterials.

[49]  D. Clegg,et al.  HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells , 2017, Nature Biotechnology.

[50]  V. Martinelli,et al.  Single-Dose Intracardiac Injection of Pro-Regenerative MicroRNAs Improves Cardiac Function After Myocardial Infarction , 2017, Circulation research.

[51]  Visar Ajeti,et al.  Myocardial Tissue Engineering With Cells Derived From Human-Induced Pluripotent Stem Cells and a Native-Like, High-Resolution, 3-Dimensionally Printed Scaffold , 2017, Circulation research.

[52]  Wei Zhu,et al.  Direct 3D bioprinting of prevascularized tissue constructs with complex microarchitecture. , 2017, Biomaterials.

[53]  T. Kasai-Brunswick,et al.  Cardiosphere-derived cells do not improve cardiac function in rats with cardiac failure , 2017, Stem Cell Research & Therapy.

[54]  Karen Abrinia,et al.  Surface acoustic waves induced micropatterning of cells in gelatin methacryloyl (GelMA) hydrogels , 2017, Biofabrication.

[55]  T. Henry,et al.  The Athena trials: Autologous adipose‐derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction , 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[56]  V. Préat,et al.  Poly(lactic acid)-based particulate systems are promising tools for immune modulation. , 2017, Acta biomaterialia.

[57]  T. Thum,et al.  Long Noncoding RNAs in Cardiovascular Pathology, Diagnosis, and Therapy. , 2016, Circulation.

[58]  H. Reichenspurner,et al.  Cardiac repair in guinea pigs with human engineered heart tissue from induced pluripotent stem cells , 2016, Science Translational Medicine.

[59]  M. Parmar,et al.  An exploratory randomized control study of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with ischaemic cardiomyopathy: the REGENERATE‐IHD clinical trial , 2016, European journal of heart failure.

[60]  Mark A. Skylar-Scott,et al.  Three-dimensional bioprinting of thick vascularized tissues , 2016, Proceedings of the National Academy of Sciences.

[61]  H. Baharvand,et al.  Human cardiomyocyte generation from pluripotent stem cells: A state-of-art. , 2016, Life sciences.

[62]  J. Mill,et al.  Multicentre, randomized, double-blind trial of intracoronary autologous mononuclear bone marrow cell injection in non-ischaemic dilated cardiomyopathy (the dilated cardiomyopathy arm of the MiHeart study). , 2015, European heart journal.

[63]  Malte Tiburcy,et al.  Human Engineered Heart Muscles Engraft and Survive Long Term in a Rodent Myocardial Infarction Model. , 2015, Circulation research.

[64]  J. Lindner,et al.  Intravenous xenogeneic transplantation of human adipose‐derived stem cells improves left ventricular function and microvascular integrity in swine myocardial infarction model , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[65]  Alain Bel,et al.  Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience. , 2015, European heart journal.

[66]  Tao Wang,et al.  A microRNA-Hippo pathway that promotes cardiomyocyte proliferation and cardiac regeneration in mice , 2015, Science Translational Medicine.

[67]  Simona Casini,et al.  Immaturity of human stem-cell-derived cardiomyocytes in culture: fatal flaw or soluble problem? , 2015, Stem cells and development.

[68]  Ying Ge,et al.  Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells. , 2014, Cell stem cell.

[69]  M. Giacca,et al.  In vivo activation of a conserved microRNA program induces mammalian heart regeneration. , 2014, Cell stem cell.

[70]  C. Feschotte,et al.  Volatile evolution of long noncoding RNA repertoires: mechanisms and biological implications. , 2014, Trends in genetics : TIG.

[71]  H. Tse,et al.  Endomyocardial Implantation of Autologous Bone Marrow Mononuclear Cells in Advanced Ischemic Heart Failure: a Randomized Placebo-Controlled Trial (END-HF) , 2014, Journal of Cardiovascular Translational Research.

[72]  R. Kalil,et al.  Direct intramyocardial transthoracic transplantation of bone marrow mononuclear cells for non-ischemic dilated cardiomyopathy: INTRACELL, a prospective randomized controlled trial , 2014, Revista brasileira de cirurgia cardiovascular : orgao oficial da Sociedade Brasileira de Cirurgia Cardiovascular.

[73]  P. Serruys,et al.  Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: The PRECISE Trial. , 2014, American heart journal.

[74]  J. Sinisalo,et al.  Autologous bone marrow mononuclear cell transplantation in ischemic heart failure: a prospective, controlled, randomized, double-blind study of cell transplantation combined with coronary bypass. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[75]  P. Fedak,et al.  Epicardial infarct repair with basic fibroblast growth factor-enhanced CorMatrix-ECM biomaterial attenuates postischemic cardiac remodeling. , 2014, The Journal of thoracic and cardiovascular surgery.

[76]  Charles E. Murry,et al.  Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate Non-Human Primate Hearts , 2014, Nature.

[77]  Y. Shiba,et al.  Electrical Integration of Human Embryonic Stem Cell-Derived Cardiomyocytes in a Guinea Pig Chronic Infarct Model , 2014, Journal of cardiovascular pharmacology and therapeutics.

[78]  Manolis Kellis,et al.  Evolutionary dynamics and tissue specificity of human long noncoding RNAs in six mammals , 2014, Genome research.

[79]  Shengshou Hu,et al.  A pilot trial of autologous bone marrow mononuclear cell transplantation through grafting artery: a sub-study focused on segmental left ventricular function recovery and scar reduction. , 2013, International journal of cardiology.

[80]  E. Marbán,et al.  Validation of Contrast-Enhanced Magnetic Resonance Imaging to Monitor Regenerative Efficacy After Cell Therapy in a Porcine Model of Convalescent Myocardial Infarction , 2013, Circulation.

[81]  S. Soker,et al.  Organ bioengineering and regeneration as the new Holy Grail for organ transplantation. , 2013, Annals of surgery.

[82]  G. Wang,et al.  mir-17–92 Cluster Is Required for and Sufficient to Induce Cardiomyocyte Proliferation in Postnatal and Adult Hearts , 2013, Circulation research.

[83]  A. Zeiher,et al.  Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial. , 2013, JAMA.

[84]  E. Marbán,et al.  Allogeneic cardiospheres safely boost cardiac function and attenuate adverse remodeling after myocardial infarction in immunologically mismatched rat strains. , 2013, Journal of the American College of Cardiology.

[85]  I. Sancho-Martinez,et al.  Reprogramming toward heart regeneration: stem cells and beyond. , 2013, Cell stem cell.

[86]  Diana C. Canseco,et al.  Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family , 2012, Proceedings of the National Academy of Sciences.

[87]  L. Zentilin,et al.  Functional screening identifies miRNAs inducing cardiac regeneration , 2012, Nature.

[88]  Takashi Daimon,et al.  Feasibility, Safety, and Therapeutic Efficacy of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Sheets in a Porcine Ischemic Cardiomyopathy Model , 2012, Circulation.

[89]  Yuyin Li,et al.  Attenuation of p38-Mediated miR-1/133 Expression Facilitates Myoblast Proliferation during the Early Stage of Muscle Regeneration , 2012, PloS one.

[90]  J. Mattick,et al.  Genome-wide analysis of long noncoding RNA stability , 2012, Genome research.

[91]  Dejian Lai,et al.  Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. , 2012, JAMA.

[92]  Daniel Berman,et al.  Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial , 2012, The Lancet.

[93]  Gregory B. Lim.  Stem cells: Myocardial regeneration after infarction—promising phase I trial results , 2012, Nature Reviews Cardiology.

[94]  Patrick W Serruys,et al.  First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction. , 2012, Journal of the American College of Cardiology.

[95]  E. Olson,et al.  Inhibition of miR-15 Protects Against Cardiac Ischemic Injury , 2012, Circulation research.

[96]  E. Marbán,et al.  Safety and Efficacy of Allogeneic Cell Therapy in Infarcted Rats Transplanted With Mismatched Cardiosphere-Derived Cells , 2012, Circulation.

[97]  D. Bartel,et al.  Conserved Function of lincRNAs in Vertebrate Embryonic Development despite Rapid Sequence Evolution , 2011, Cell.

[98]  Kam W Leong,et al.  Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function. , 2011, Biomaterials.

[99]  Doris A Taylor,et al.  Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. , 2011, JAMA.

[100]  G. Dorn,et al.  miR-15 Family Regulates Postnatal Mitotic Arrest of Cardiomyocytes , 2011, Circulation research.

[101]  S. Sahoo,et al.  PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. , 2011, Advanced drug delivery reviews.

[102]  J. Gold,et al.  Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats. , 2010, Journal of molecular and cellular cardiology.

[103]  N. Dib,et al.  Efficiency of Intramyocardial Injections of Autologous Bone Marrow Mononuclear Cells in Patients with Ischemic Heart Failure: A Randomized Study , 2010, Journal of cardiovascular translational research.

[104]  C. Ponting,et al.  Catalogues of mammalian long noncoding RNAs: modest conservation and incompleteness , 2009, Genome Biology.

[105]  E. Marbán,et al.  Validation of the Cardiosphere Method to Culture Cardiac Progenitor Cells from Myocardial Tissue , 2009, PloS one.

[106]  Tal Dvir,et al.  Prevascularization of cardiac patch on the omentum improves its therapeutic outcome , 2009, Proceedings of the National Academy of Sciences.

[107]  D. Srivastava,et al.  MicroRNA regulation of cardiovascular development. , 2009, Circulation research.

[108]  A. Zeiher,et al.  Cell Therapy of Acute Myocardial Infarction: Open Questions , 2008, Cardiology.

[109]  E. Olson,et al.  microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. , 2008, Genes & development.

[110]  H. Huikuri,et al.  Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. , 2008, European heart journal.

[111]  C. Kubal,et al.  Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone , 2008, Nature Clinical Practice Cardiovascular Medicine.

[112]  Jeroen Rouwkema,et al.  Vascularization in tissue engineering. , 2008, Trends in biotechnology.

[113]  O. Alfieri,et al.  The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial: First Randomized Placebo-Controlled Study of Myoblast Transplantation , 2008, Circulation.

[114]  J. Jung,et al.  Improvement of cardiac function and remodeling by transplanting adipose tissue-derived stromal cells into a mouse model of acute myocardial infarction. , 2007, International journal of cardiology.

[115]  C. Ware,et al.  The FASEB Journal • Research Communication , 2007 .

[116]  Michael T. McManus,et al.  Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2 , 2007, Cell.

[117]  E. Marbán,et al.  Regenerative Potential of Cardiosphere-Derived Cells Expanded From Percutaneous Endomyocardial Biopsy Specimens , 2007, Circulation.

[118]  K. Furie,et al.  Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2007, Circulation.

[119]  A. Zeiher,et al.  Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. , 2006, The New England journal of medicine.

[120]  A. Zeiher,et al.  Transcoronary transplantation of progenitor cells after myocardial infarction. , 2006, The New England journal of medicine.

[121]  E. Taraldsrud,et al.  Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. , 2006, The New England journal of medicine.

[122]  C. Nienaber,et al.  G-CSF in acute myocardial infarction - experimental and clinical findings. , 2006, Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology.

[123]  É. Mousseaux,et al.  Skeletal Myoblast Transplantation in Ischemic Heart Failure: Long-Term Follow-Up of the First Phase I Cohort of Patients , 2006, Circulation.

[124]  S. Dietrich,et al.  Establishment of the epaxial–hypaxial boundary in the avian myotome , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.

[125]  A. Ganser,et al.  Intracoronary Bone Marrow Cell Transfer After Myocardial Infarction: Eighteen Months’ Follow-Up Data From the Randomized, Controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) Trial , 2006, Circulation.

[126]  S. Dymarkowski,et al.  Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial , 2006, The Lancet.

[127]  B. Griffith,et al.  Safety and Feasibility of Autologous Myoblast Transplantation in Patients With Ischemic Cardiomyopathy: Four-Year Follow-Up , 2005, Circulation.

[128]  H. Vogel,et al.  Embryonic Stem Cell Immunogenicity Increases Upon Differentiation After Transplantation Into Ischemic Myocardium , 2005, Circulation.

[129]  W. Wijns,et al.  Intracoronary Injection of CD133-Positive Enriched Bone Marrow Progenitor Cells Promotes Cardiac Recovery After Recent Myocardial Infarction: Feasibility and Safety , 2005, Circulation.

[130]  W. Hofmann,et al.  Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. , 2004, Journal of the American College of Cardiology.

[131]  J. García-Sancho,et al.  Experimental and Clinical Regenerative Capability of Human Bone Marrow Cells After Myocardial Infarction , 2004, Circulation research.

[132]  D. Fiszer,et al.  Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. , 2004, American heart journal.

[133]  Bernd Hertenstein,et al.  Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial , 2004, The Lancet.

[134]  Fei Ye,et al.  Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. , 2004, The American journal of cardiology.

[135]  B. Fleischmann,et al.  Bone marrow–derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation , 2004, Nature Medicine.

[136]  David A. Williams,et al.  Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts , 2004, Nature.

[137]  I. Weissman,et al.  Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium , 2004, Nature.

[138]  F. Prósper,et al.  Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. , 2003, European heart journal.

[139]  Arjun Deb,et al.  Bone Marrow–Derived Cardiomyocytes Are Present in Adult Human Heart: A Study of Gender-Mismatched Bone Marrow Transplantation Patients , 2003, Circulation.

[140]  F. Pagani,et al.  Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. , 2003, Journal of the American College of Cardiology.

[141]  Min Zhu,et al.  Human adipose tissue is a source of multipotent stem cells. , 2002, Molecular biology of the cell.

[142]  P. Wernet,et al.  Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in Humans , 2002, Circulation.

[143]  Chunhui Xu,et al.  Characterization and Enrichment of Cardiomyocytes Derived From Human Embryonic Stem Cells , 2002, Circulation research.

[144]  C. Verfaillie,et al.  Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. , 2001, Blood.

[145]  G. Cossu,et al.  Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: Implications for myocardium regeneration , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[146]  Federica Limana,et al.  Mobilized bone marrow cells repair the infarcted heart, improving function and survival , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[147]  H. Blau,et al.  The Evolving Concept of a Stem Cell Entity or Function? , 2001, Cell.

[148]  M. Entman,et al.  Stem Cell Plasticity in Muscle and Bone Marrow , 2001, Annals of the New York Academy of Sciences.

[149]  M. Entman,et al.  Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. , 2001, The Journal of clinical investigation.

[150]  Neil D. Theise,et al.  Multi-Organ, Multi-Lineage Engraftment by a Single Bone Marrow-Derived Stem Cell , 2001, Cell.

[151]  David M. Bodine,et al.  Bone marrow cells regenerate infarcted myocardium , 2001, Nature.

[152]  H. Lorenz,et al.  Multilineage cells from human adipose tissue: implications for cell-based therapies. , 2001, Tissue engineering.

[153]  A. Hagège,et al.  Myoblast transplantation for heart failure , 2001, The Lancet.

[154]  A. Hagège,et al.  Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. , 2000, The Journal of thoracic and cardiovascular surgery.

[155]  S. Ogawa,et al.  Cardiomyocytes can be generated from marrow stromal cells in vitro. , 1999, The Journal of clinical investigation.

[156]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[157]  Doris A Taylor,et al.  Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation , 1998, Nature Medicine.

[158]  S M Schwartz,et al.  Skeletal myoblast transplantation for repair of myocardial necrosis. , 1996, The Journal of clinical investigation.

[159]  R. C. Chiu,et al.  Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation. , 1995, The Annals of thoracic surgery.

[160]  Jürgen Hescheler,et al.  Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, atrial and ventricular cell types , 1993, Mechanisms of Development.

[161]  A. Yeung,et al.  Relations Between Heart Rate, Ischemia, and Drug Therapy During Daily Life in Patients With Coronary Artery Disease , 1990, Circulation.

[162]  J. Ross,et al.  Fiber Orientation in the Canine Left Ventricle during Diastole and Systole , 1969, Circulation research.

[163]  R. Ardehali,et al.  In Vitro Generation of Heart Field Specific Cardiomyocytes. , 2022, Methods in molecular biology.

[164]  M. Doblaré,et al.  Epicardial delivery of collagen patches with adipose-derived stem cells in rat and minipig models of chronic myocardial infarction. , 2014, Biomaterials.

[165]  C. Rurali,et al.  [Separation and quantitative evaluation of nucleotides in pharmaceutical specialties by means of high-pressure liquid chromatography]. , 1975, Il Farmaco; edizione pratica.